Has Frank Miller received payments from drug or device companies?

Yes. Drug and device makers reported $1,702 in general payments to Frank Miller across 90 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Frank Miller did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Frank Miller come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Frank Miller

Internal Medicine · Russell Springs, KYNPI 1770553067

Payments from drug & device makers

$1,702in general payments, 2019–2025

Across 90 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$416
Pfizer$182
AbbVie$164
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$149
E.r. Squibb & Sons, L.L.C.$94
Bayer$87
plus $610 from 15 others

What the payments were for

Food & beverage$1,702100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	18	$416
Pfizer	10	$182
AbbVie	9	$164
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	9	$149
E.r. Squibb & Sons, L.L.C.	6	$94
Bayer	6	$87
Shield Therapeutics Inc	1	$79
Lilly USA, LLC	5	$76
Johnson & Johnson	4	$72
Boehringer Ingelheim	4	$65
Vanda Pharmaceuticals Inc.	3	$60
Amgen	2	$39
Novo Nordisk	2	$38
Otsuka America Pharmaceutical, Inc.	2	$35
Axsome Therapeutics, Inc.	2	$30
Exact Sciences	2	$29
Novartis	1	$22
GSK	1	$20
Mylan Specialty L.p.	1	$16
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$15
Astellas Pharma US Inc	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,702 in reported general payments places this provider in the 70th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	18	$13,662
JardianceEmpagliflozin	11	$10,939
FarxigaDapagliflozin Propanediol	16	$7,273
Levothyroxine Sodium	36	$985
CefuroximeCefuroxime Axetil	85	$868
Albuterol Sulfate HfaAlbuterol Sulfate	11	$643
ValacyclovirValacyclovir Hcl	12	$533
Duloxetine Hcl	52	$423
Losartan Potassium	43	$417
Metoprolol Succinate	27	$340
Insulin SyringeSyringe-Needle,insulin,0.5 Ml	11	$329
Prednisone	176	$312
Potassium Chloride	23	$235
Metformin Hcl	27	$231
Pantoprazole Sodium	30	$194

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$182	$13,66218 claims
Boehringer IngelheimJardiance	$65	$10,93911 claims
AstraZenecaFarxiga	$416	$7,27316 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,284 internal medicine providers in Kentucky.

Other internal medicine in Russell Springs

Mark AdamsLondon$15.4M
Matthew WenkerErlanger$12.8M
Jason ChesneyLouisville$6.3M
Neil FarrisLexington$3M
David JohnsonOwensboro$787K
Hollis ClarkMurray$780K
Fares KhaterWhitesburg$412K
Christopher PhillipsPaducah$315K
Cynthia Bowman-StroudPaducah$234K
Bernard BuchananOwensboro$224K

See the full list for Kentucky →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →